ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.

MLA

Poussier, Sylvain, et al. “ECG-Triggered 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging of the Rat Heart Is Dramatically Enhanced by Acipimox.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 9, Aug. 2010, pp. 1745–50. EBSCOhost, https://doi.org/10.1007/s00259-010-1418-0.

APA

Poussier, S., Maskali, F., Tran, N., Person, C., Maureira, P., Boutley, H., Karcher, G., Lacolley, P., Régnault, V., Fay, R., & Marie, P. Y. (2010). ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox. European Journal of Nuclear Medicine and Molecular Imaging, 37(9), 1745–1750. https://doi.org/10.1007/s00259-010-1418-0

Chicago

Poussier, Sylvain, Fatiha Maskali, Nguyen Tran, Christophe Person, Pablo Maureira, Henri Boutley, Gilles Karcher, et al. 2010. “ECG-Triggered 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging of the Rat Heart Is Dramatically Enhanced by Acipimox.” European Journal of Nuclear Medicine and Molecular Imaging 37 (9): 1745–50. doi:10.1007/s00259-010-1418-0.